Stocks CRCT Financial statements
Financial statementsCricut, Inc. financial statements
Income statement, balance sheet and cash flow statement for the last 7 fiscal years, taken from the XBRL data Cricut, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2019 | FY2021 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | 487 | 959 | 1,306 | 886 | 765 | 713 | 709 |
| Cost of revenue | 344 | 627 | 849 | 536 | 422 | 360 | 318 |
| Gross profit | 142 | 332 | 457 | 350 | 343 | 353 | 390 |
| Research and development | 26.7 | 38.9 | 79.8 | 76.9 | 65 | 60.4 | 66.5 |
| Selling and marketing | 40.1 | 63.3 | 134 | 130 | 123 | 143 | 159 |
| General and administrative | 22 | 29.6 | 51.3 | 62.6 | 85.1 | 73 | 68.5 |
| Operating expenses | 88.8 | 132 | 265 | 270 | 273 | 277 | 294 |
| Operating income | 53.6 | 201 | 192 | 80 | 70 | 76.1 | 96 |
| Interest expense | 0.3 | 0.29 | 0.32 | 0.33 | 0.57 | ||
| Other non-operating income | -3.29 | -1.32 | -0.03 | 2.03 | 9.8 | 12.8 | 11.9 |
| Pre-tax income | 50.3 | 199 | 192 | 82 | 79.8 | 88.9 | 108 |
| Income tax | 11.1 | 44.6 | 51.9 | 21.3 | 26.1 | 26 | 31.2 |
| Net income | 39.2 | 155 | 140 | 60.7 | 53.6 | 62.8 | 76.7 |
| EBITDA | 62.7 | 215 | 212 | 107 | 100 | 105 | 120 |
| EPS, basic | 0.19 | 0.74 | 0.67 | 0.28 | 0.25 | 0.29 | 0.36 |
| EPS, diluted | 0.19 | 0.74 | 0.64 | 0.28 | 0.24 | 0.29 | 0.35 |
| Shares, basic (weighted) | 208 | 208 | 209 | 214 | 217 | 215 | 215 |
| Shares, diluted (weighted) | 208 | 208 | 220 | 221 | 220 | 216 | 217 |
Balance sheet
| FY2019 | FY2021 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | 6.65 | 122 | 242 | 225 | 142 | 232 | 256 |
| Short-term investments | 0 | 74.3 | 103 | 105 | 19.4 | ||
| Receivables | 163 | 200 | 137 | 111 | 102 | 92 | |
| Inventory | 249 | 454 | 381 | 278 | 134 | 114 | |
| Other current assets | 4.92 | 32.8 | 23.8 | 19.1 | 26.1 | 29.3 | |
| Total current assets | 539 | 928 | 811 | 620 | 580 | 500 | |
| Property, plant and equipment | 33.4 | 53.3 | 63.4 | 47.6 | 37.5 | 40.3 | |
| Lease right-of-use assets | 0 | 17.7 | 17.1 | 12.4 | 14 | 10.9 | |
| Intangible assets | 2.28 | 1.52 | 0.76 | 0 | |||
| Total assets | 581 | 1,006 | 950 | 750 | 693 | 581 | |
| Accounts payable | 252 | 205 | 63.2 | 76.9 | 53.4 | 71.6 | |
| Deferred revenue | 23.5 | 30.5 | 34.9 | 40.3 | 45.4 | 50.4 | |
| Total current liabilities | 347 | 308 | 254 | 196 | 203 | 221 | |
| Lease liabilities | 0 | 15.8 | 13.9 | 8.94 | 11.3 | 8.02 | |
| Other non-current liabilities | 3.22 | 3.27 | 5.11 | 6.92 | 8.76 | 5.28 | |
| Total liabilities | 352 | 332 | 277 | 215 | 226 | 237 | |
| Paid-in capital | 413 | 717 | 673 | 506 | 467 | 339 | |
| Retained earnings | -184 | -43.6 | 0 | 28.5 | 0 | 3.96 | |
| Other comprehensive income | 0.01 | -0.06 | -0.48 | 0.28 | -0.01 | 0.17 | |
| Shareholders' equity | 121 | 229 | 674 | 673 | 535 | 467 | 344 |
| Total equity | 121 | 229 | 674 | 673 | 535 | 467 | 344 |
| Total liabilities and equity | 581 | 1,006 | 950 | 750 | 693 | 581 | |
| Shares outstanding | 208 | 222 | 220 | 218 | 213 | 211 |
Cash flow statement
| FY2019 | FY2021 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|
| Net income | 39.2 | 155 | 140 | 60.7 | 53.6 | 62.8 | 76.7 |
| Depreciation and amortization | 9.18 | 14.1 | 19.4 | 27 | 30 | 29 | 24.4 |
| Stock-based compensation | 1.85 | 9.48 | 38.1 | 41.1 | 47.3 | 45.1 | 34.8 |
| Deferred income tax | -1.26 | -2.29 | -0.14 | -20.5 | -11.2 | -4.32 | 26.1 |
| Change in receivables | -4.88 | -97.6 | -37.7 | 63.7 | 23.5 | 4.89 | 12.6 |
| Change in inventory | -73.2 | -38 | -208 | 63.1 | 78.4 | 150 | 41.2 |
| Change in payables | 10.3 | 157 | -46.7 | -140 | 13.5 | -23.1 | 16.9 |
| Cash from operations | 3.86 | 248 | -105 | 118 | 288 | 265 | 200 |
| Purchases of investments | 0 | 0 | -180 | -63.5 | -111 | 0 | |
| Cash from investing | -14.1 | -21.8 | -35.8 | -108 | -48.8 | -18.3 | 60.7 |
| Stock issued | 0 | 0 | 0.27 | 0.03 | 0.38 | 0 | 0 |
| Share buybacks | 0 | 0 | -18.6 | -20.3 | -38.5 | -24.7 | |
| Dividends paid | 0 | -51.2 | 0 | 0 | -294 | -110 | -202 |
| Cash from financing | 10.9 | -111 | 260 | -26.2 | -322 | -156 | -237 |
| Exchange rate effect | -0.03 | 0.09 | -0.13 | -0.22 | 0.11 | -0.25 | 0.63 |
| Net change in cash | 0.64 | 116 | 119 | -16.7 | -82.8 | 90 | 24.1 |
| Interest paid | 3.3 | 1.31 | 0.01 | 0 | 0 | 0 | |
| Income taxes paid | 6.65 | 42.3 | 81.1 | 28.9 | 24 | 43.9 | 10.5 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Gross margin | 57.9% | Gross profit / revenue. |
| Operating margin | 15.5% | Operating income / revenue. |
| EBITDA margin | 19.0% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Pre-tax margin | 16.9% | Pre-tax income / revenue. |
| Net margin | 12.7% | Net income / revenue. |
| Operating cash flow margin | 26.1% | Cash from operations / revenue. |
| Effective tax rate | 25.0% | Income tax / pre-tax income, when pre-tax income is positive. |
| Return on equity (ROE) | 23.8% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | 15.0% | Net income / average total assets. |
| Return on invested capital (ROIC) | 79.2% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
| R&D / revenue | 9.8% | Research and development expense / revenue. |
| Stock-based pay / revenue | 3.9% | Stock-based compensation (from the cash flow statement) / revenue. |
| D&A / revenue | 3.5% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | -0.5% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | -7.2% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Revenue CAGR, 5y | -5.9% | Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Gross profit growth, 1y | 10.7% | Gross profit vs the same period a year earlier. Only from a positive base. |
| Gross profit CAGR, 3y | 3.7% | Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Gross profit CAGR, 5y | 3.3% | Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating income growth, 1y | 26.2% | Operating income vs the same period a year earlier. Only from a positive base. |
| Operating income CAGR, 3y | 6.3% | Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating income CAGR, 5y | -13.7% | Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| EBITDA growth, 1y | 14.6% | EBITDA vs the same period a year earlier. Only from a positive base. |
| EBITDA CAGR, 3y | 4.1% | Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EBITDA CAGR, 5y | -10.9% | Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Net income growth, 1y | 22.1% | Net income vs the same period a year earlier. Only from a positive base. |
| Net income CAGR, 3y | 8.1% | Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Net income CAGR, 5y | -13.1% | Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| EPS growth, 1y | 20.7% | EPS vs the same period a year earlier. Only from a positive base. |
| EPS CAGR, 3y | 7.7% | Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EPS CAGR, 5y | -13.9% | Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating cash flow growth, 1y | -24.4% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Operating cash flow CAGR, 3y | 19.4% | Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating cash flow CAGR, 5y | -4.2% | Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Book value growth, 1y | -26.4% | Book value vs the same period a year earlier. Only from a positive base. |
| Book value CAGR, 3y | -20.1% | Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Book value CAGR, 5y | 8.5% | Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Total assets growth, 1y | -16.2% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | -15.1% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets CAGR, 5y | -0.0% | Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Share count change, 1y | 0.8% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 3y | -0.5% | Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 5y | 0.9% | Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 2.49x | Current assets / current liabilities. |
| Quick ratio | 1.78x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 1.42x | (Cash + short-term investments) / current liabilities. |
| Liabilities / assets | 37.1% | Total liabilities / total assets. |
| Working capital | $299.1M | Current assets - current liabilities. |
| Tangible book value | $368.2M | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 1.18x | Revenue / average total assets. |
| Fixed asset turnover | 14.3x | Revenue / average property, plant and equipment. |
| Inventory turnover | 2.61x | Cost of revenue / average inventory. |
| Days inventory | 140 days | 365 x average inventory / cost of revenue. |
| Receivables turnover | 9.57x | Revenue / average receivables. |
| Days sales outstanding | 38 days | 365 x average receivables / revenue. |
| Days payables | 69 days | 365 x average accounts payable / cost of revenue. |
| Cash conversion cycle | 109 days | Days inventory + days sales outstanding - days payables. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | $0.42 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| Revenue per share | $3.27 | Revenue / diluted weighted shares. |
| Operating cash flow per share | $0.85 | Cash from operations / diluted weighted shares. |
| Book value per share | $1.76 | Shareholders' equity / shares outstanding (diluted weighted shares when not reported). |
| Tangible book per share | $1.76 | Tangible book value / shares outstanding. |
| Cash per share | $1.37 | (Cash + short-term investments) / shares outstanding. |
| Payout ratio | 230.1% | Dividends paid / net income, when net income is positive. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $1.29B | Share price x shares outstanding. |
| Enterprise value | $999.7M | Market cap + total debt - cash - short-term investments. |
| P/E | 14.7x | Market cap / net income. Only when net income is positive. |
| P/S | 1.86x | Market cap / revenue. |
| P/B | 3.49x | Market cap / shareholders' equity. Only when equity is positive. |
| Price / tangible book | 3.49x | Market cap / tangible book value, when positive. |
| P/OCF | 7.14x | Market cap / cash from operations, when positive. |
| EV/Sales | 1.45x | Enterprise value / revenue. |
| EV/EBIT | 9.35x | Enterprise value / operating income, when both are positive. |
| EV/EBITDA | 7.63x | Enterprise value / EBITDA, when both are positive. |
| Earnings yield | 6.8% | Net income / market cap (the inverse of P/E). |
| Dividend yield | 15.7% | Dividends paid over the period / market cap. |
| Shareholder yield | 17.9% | (Dividends paid + share buybacks) / market cap. |
| PEG | 1.90x | P/E / EPS growth per year over 3 years (in percent). Only when both are positive. |
What was Cricut, Inc.'s revenue in fiscal 2025?
Cricut, Inc. reported revenue of $708.8M for fiscal 2025, 0.5% lower than the year before.
Was Cricut, Inc. profitable in fiscal 2025?
Yes. Net income was $76.7M, a net margin of 10.8%.